207 related articles for article (PubMed ID: 26952317)
21. Influence of mucolytic therapy on respiratory mechanics in patients with chronic obstructive pulmonary disease.
Schreiber J; Bohnsteen B; Rosahl W
Eur J Med Res; 2002 Mar; 7(3):98-102. PubMed ID: 11953279
[TBL] [Abstract][Full Text] [Related]
22. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Beeh KM; Beier J; Candler H; Wittig T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
[TBL] [Abstract][Full Text] [Related]
23. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
[TBL] [Abstract][Full Text] [Related]
24. Usefulness of impulse oscillometry for the assessment of airway hyperresponsiveness in mild-to-moderate adult asthma.
Short PM; Anderson WJ; Manoharan A; Lipworth BJ
Ann Allergy Asthma Immunol; 2015 Jul; 115(1):17-20. PubMed ID: 26123421
[TBL] [Abstract][Full Text] [Related]
25. Effect of CArbocisteine in Prevention of exaceRbation of chronic obstructive pulmonary disease (CAPRI study): An observational study.
Esposito A; Valentino MR; Bruzzese D; Bocchino M; Ponticiello A; Stanziola A; Sanduzzi A
Pulm Pharmacol Ther; 2016 Apr; 37():85-8. PubMed ID: 26970503
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study.
LaForce C; Feldman G; Spangenthal S; Eckert JH; Henley M; Patalano F; D'Andrea P
Int J Chron Obstruct Pulmon Dis; 2016; 11():1233-43. PubMed ID: 27354782
[TBL] [Abstract][Full Text] [Related]
27. Assessment of spirometry and impulse oscillometry in relation to asthma control.
Manoharan A; Anderson WJ; Lipworth J; Lipworth BJ
Lung; 2015 Feb; 193(1):47-51. PubMed ID: 25516285
[TBL] [Abstract][Full Text] [Related]
28. Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease.
Pisi R; Aiello M; Zanini A; Tzani P; Paleari D; Marangio E; Spanevello A; Nicolini G; Chetta A
Int J Chron Obstruct Pulmon Dis; 2015; 10():1191-7. PubMed ID: 26150710
[TBL] [Abstract][Full Text] [Related]
29. Safety and tolerability of the inhaled phosphodiesterase 4 inhibitor GSK256066 in moderate COPD.
Watz H; Mistry SJ; Lazaar AL;
Pulm Pharmacol Ther; 2013 Oct; 26(5):588-95. PubMed ID: 23701917
[TBL] [Abstract][Full Text] [Related]
30. Simvastatin Suppresses Airway IL-17 and Upregulates IL-10 in Patients With Stable COPD.
Maneechotesuwan K; Wongkajornsilp A; Adcock IM; Barnes PJ
Chest; 2015 Nov; 148(5):1164-76. PubMed ID: 26043025
[TBL] [Abstract][Full Text] [Related]
31. Effects of aminoguanidine, an inhibitor of inducible nitric oxide synthase, on nitric oxide production and its metabolites in healthy control subjects, healthy smokers, and COPD patients.
Brindicci C; Ito K; Torre O; Barnes PJ; Kharitonov SA
Chest; 2009 Feb; 135(2):353-367. PubMed ID: 18719059
[TBL] [Abstract][Full Text] [Related]
32. Mucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - A Double-Blind, Randomized Controlled Trial.
Koppitz M; Eschenburg C; Salzmann E; Rosewich M; Schubert R; Zielen S
PLoS One; 2016; 11(6):e0156999. PubMed ID: 27308826
[TBL] [Abstract][Full Text] [Related]
33. Relationships between impulse oscillometry, spirometry and dyspnoea in COPD.
Anderson WJ; Lipworth BJ
J R Coll Physicians Edinb; 2012 Jun; 42(2):111-5. PubMed ID: 22693693
[TBL] [Abstract][Full Text] [Related]
34. Exhaled nitric oxide for monitoring childhood asthma inflammation compared to sputum analysis, serum interleukins and pulmonary function.
Paro-Heitor ML; Bussamra MH; Saraiva-Romanholo BM; Martins MA; Okay TS; Rodrigues JC
Pediatr Pulmonol; 2008 Feb; 43(2):134-41. PubMed ID: 18085692
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of erdosteine 900 versus 600 mg/day in reducing oxidative stress in patients with COPD exacerbations: Results of a double blind, placebo-controlled trial.
Dal Negro RW; Visconti M; Turco P
Pulm Pharmacol Ther; 2015 Aug; 33():47-51. PubMed ID: 26116425
[TBL] [Abstract][Full Text] [Related]
36. Airway responsiveness to adenosine after a single dose of fluticasone propionate discriminates asthma from COPD.
Spicuzza L; Scuderi V; Morjaria JB; Prosperini G; Arcidiacono G; Caruso M; Folisi C; Di Maria GU; Polosa R
Pulm Pharmacol Ther; 2014 Feb; 27(1):70-5. PubMed ID: 23688422
[TBL] [Abstract][Full Text] [Related]
37. Importance of fractional exhaled nitric oxide in the differentiation of asthma-COPD overlap syndrome, asthma, and COPD.
Chen FJ; Huang XY; Liu YL; Lin GP; Xie CM
Int J Chron Obstruct Pulmon Dis; 2016; 11():2385-2390. PubMed ID: 27713629
[TBL] [Abstract][Full Text] [Related]
38. Impulse oscillometry may be of value in detecting early manifestations of COPD.
Frantz S; Nihlén U; Dencker M; Engström G; Löfdahl CG; Wollmer P
Respir Med; 2012 Aug; 106(8):1116-23. PubMed ID: 22613172
[TBL] [Abstract][Full Text] [Related]
39. The application of impulse oscillation system for the evaluation of treatment effects in patients with COPD.
Mineshita M; Shikama Y; Nakajima H; Nishihira R; Komatsu S; Kubota M; Kobayashi H; Kokubu F; Shinkai M; Kaneko T; Miyazawa T;
Respir Physiol Neurobiol; 2014 Oct; 202():1-5. PubMed ID: 25046279
[TBL] [Abstract][Full Text] [Related]
40. Relationship between small airway function and health status, dyspnea and disease control in asthma.
Takeda T; Oga T; Niimi A; Matsumoto H; Ito I; Yamaguchi M; Matsuoka H; Jinnai M; Otsuka K; Oguma T; Nakaji H; Chin K; Mishima M
Respiration; 2010; 80(2):120-6. PubMed ID: 19776554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
